Bromelain Market Rising at 7.5% CAGR to Reach US$ 56.2 Million by 2034: Fact.MR Report

Increasing Preference for Enzyme-based Food Ingredients Driving Lucrative Opportunities for Bromelain Suppliers


Rockville , Dec. 04, 2023 (GLOBE NEWSWIRE) -- Fact.MR, a market research and competitive intelligence provider, in its newly published market research report, reveals that the global Bromelain Market is estimated to be valued at US$ 27.3 million in 2024 and expand at a CAGR of 7.5% from 2024 to 2034.

The proteolytic nature of bromelain is predicted to stimulate its demand in several industries, including food & beverages. Bromelain is used in the food & beverages industry as a meat tenderizer. Several added health benefits of bromelain in boosting immunity and anti-inflammation are driving its demand in dietary supplements.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9158

Key Segments of Bromelain Industry Research Report

By Product TypeBy FormBy Enzyme StrengthBy ApplicationBy Region
  • Stem Bromelain
  • Fruit Bromelain
  • Powder
  • Liquid
  • Low
  • Medium
  • High
  • Healthcare
  • Meat & Seafood
  • Dietary Supplements
  • Cosmetics
  • Industrial
  • Animal Feed
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA


Rapidly increasing sales of bromelain are attributed to the growing demand for ready-to-cook meat dishes and processed meat. Bromelain is used extensively to tenderize red meat. Conventional techniques for meat tenderization use marination, which needs a noteworthy amount of resources and is time-consuming. However, bromelain with inherent tenderization properties is gaining traction as it reduces production costs and minimizes preparation time as well.

As an anti-inflammatory agent, bromelain helps reduce swelling and works effectively to heal stomach infections. It is also used for rapid recovery of burns through oral consumption as well as direct application.

Key Takeaway from Market Study

  • The global bromelain market is pegged at US$ 27.3 million in 2024.
  • Worldwide demand for bromelain is forecasted to reach a market value of US$ 56.2 million by the end of 2034.
  • The market is projected to expand at 7.5% CAGR from 2024 to 2034.
  • North America is predicted to account for 22.1% share of global market revenue in 2024.
  • Sales of bromelain in Japan are forecasted to rise at 7.2% CAGR from 2024 to 2034.
  • The market in Canada is projected to expand at a CAGR of 7.1% through 2034.
  • The healthcare segment is predicted to account for 54.2% share of the global market in 2024.

“Rising demand for plant-based and natural food products along with growing adoption of health supplements are predicted to stimulate demand for bromelain across geographies,” says a Fact.MR analyst.

Demand for Powdered Bromelain Driven by Enhanced Flexibility in Controlling Concentration and Dosage

The powdered form of bromelain is used significantly due to its easy incorporation into several formulations, including food products and dietary supplements. Manufacturers can control the concentration and dosage of bromelain in products, thereby making the powdered form more suitable for customization.

Competitive Overview

The market features both multinational and regional companies, with multinational players holding a substantial 45% to 50% share of the global market in 2023. These companies provide a diverse range of products centered around bromelain. Key players are prioritizing efficient supply chain management, product quality assurance, advancements, and collaborations.

  • For example, in April 2020, Enzybel International joined the Belgian Health Ingredients Group (BHIG), with its bromelain production unit receiving GMP pharma certification.

Leading Market Players

Advanced Enzyme Technologies, Biolaxi Corporation, Creative Enzymes, Antozyme Biotech Pvt. Ltd., Botanic Healthcare, Dayang Chem (Hangzhou) Co. Ltd, Enzyme Technology (PTY) Ltd., Enzybel Group, Hong Mao Biochemicals Co., Ltd., Undersun Biomedtech Co., Ltd., Mitushi Biopharma, and Guangxi Narrning Jevely Biological Products Co. are leading manufacturers of bromelain.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9158

Report AttributeDetails
Value Projection (2034)USD 56.2 Million
Growth Rate (2024-2034)7.5% CAGR
No. of pages170 Pages
No. of Tables80 Tables
No. of Figures219 Figures


According to a recent report from Fact.MR, the powdered form of bromelain is expected to play a significant role in global market revenue due to its widespread utilization in various formulations, including food products and dietary supplements. Manufacturers find the powdered form conducive for customization as it allows control over bromelain concentration and dosage.

Bromelain with high enzyme strength is anticipated to capture a 44.6% share of the global market by 2034. This variant offers increased efficiency in smaller doses, making it preferred by consumers seeking more potent products with therapeutic benefits.

In terms of application, the healthcare segment is projected to account for 53.2% of the global market revenue by 2034. The growing adoption of bromelain in the healthcare sector is attributed to its anti-inflammatory properties. Additionally, bromelain is utilized in treating specific stomach infections and reducing swelling, while as a nutritional supplement, it aids in expediting the healing of burns.

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the bromelain market, presenting historical demand data for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on product type (stem bromelain, fruit bromelain), form (powder, liquid), enzyme strength (low, medium, high), and application (healthcare, meat & seafood, dietary supplements, cosmetics, industrial, animal feed), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).

Checkout More Related Studies Published by Fact.MR Research:

Frozen Seafood Market: The global frozen seafood market is predicted to increase from a valuation of US$ 28 billion in 2023 to US$ 48 billion by the end of 2033, market expanding at a CAGR of 5.5%.

Dietary Supplements Market: The global dietary supplements market is anticipated to secure a market value of US$D 163 Billion in 2022 and reach US$ 351 Billion by 2032.

Animal Feed Probiotics Market: The global animal feed probiotics market is anticipated to expand at a CAGR of 9.1%, increasing from its current value of US$ 5 billion to US$ 12 billion by the end of 2032.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Teamsales@factmr.com
Follow Us: LinkedIn | Twitter | Blog


Recommended Reading